The Good Virus – DW – 07/30/2025
Do they offer a way out of the antibiotics crisis?
Every year, around 1.3 million people die because of antibiotic resistance. According to the World Health Organization (WHO), this is one of the biggest threats to global health.
There are various reasons for the growing number of antibiotic resistances: Unspecific or incorrect use of antibiotics causes bacteria to mutate into multi-resistant germs.
In addition, the excessive use of antibiotics in animal husbandry has alarming consequences for humans: Antibiotics, which were considered one of medicine's greatest achievements against infections, are increasingly losing their effectiveness. Increasingly, science is relying on the potential of bacteria-eating viruses, or bacteriophages, to combat bacteria.
Researchers from the US, Georgia, Kenya and Uganda are developing suitable phage therapies and establishing international collaborations. And they're finding what they're looking for in bacteria-contaminated wastewater.
Phage samples from the US and African countries will help to build up a biobank and produce specific phage cocktails. Phage therapy has not yet been approved in Germany due to a lack of clinical studies.
However, in some countries, such as Georgia and Slovakia, bacteriophages are being used successfully to treat patients with antibiotic resistances.
DW English
FRI 15.08.2025 – 01:15 UTC
FRI 15.08.2025 – 04:15 UTC
SAT 16.08.2025 – 13:15 UTC
SUN 17.08.2025 – 19:15 UTC
MON 18.08.2025 – 09:15 UTC
MON 18.08.2025 – 16:15 UTC
MON 18.08.2025 – 21:15 UTC
WED 20.08.2025 – 12:15 UTC
Lagos UTC +1 | Cape Town UTC +2 | Nairobi UTC +3
Delhi UTC +5,5 | Bangkok UTC +7 | Hong Kong UTC +8
London UTC +1 | Berlin UTC +2 | Moscow UTC +3
San Francisco UTC -7 | Edmonton UTC -6 | New York UTC -4
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
DW
2 days ago
- DW
Why do African elites seek medical treatment abroad? – DW – 08/04/2025
The deaths of former presidents Muhammadu Buhari and Edgar Lungu in foreign medical facilities have again sparked debate on whether African leaders trust their countries' healthcare systems. Choosing where to seek medical help is a deeply private decision. But the numerous occasions African leaders have sought treatment abroad have thrown the spotlight on local healthcare investment. To a large extent, leaders are responsible for the development of proper health care for the citizens of their countries. The deaths of former leaders Muhammadu Buhariand Edgar Lungu in foreign medical facilities have not calmed accusations that African leaders neglect public health systems in their own countries. "The state of health care in Nigeriais deeply concerning. The biggest problem is infrastructure. There are no drugs and functional medical equipment," Jamila Atiku, a researcher on public health in Nigeria, told DW. Reasons for medical tourism include: lack of specialized treatment available locally, poorly equipped hospitals, and security fears for politicians. Another factor, according to Zimbabwean health rights advocate Chamunorwa Mashoko, is an over-reliance on foreign aid. "Among African countries, over 32 out of 54 countries are not allocating significant budgets to health. This is motivated by overdependency on donor aid," he told DW. "Africa is failing to realize that foreign funding in health is just for diplomacy. Those assisting us with all that aid, it is really nothing to do with our health challenges," Mashoko added. African countries receive in excess of $60 billion (€52 billion) in health funding, representing just a fraction of the total health financing needed for the continent. Under the 2001 Abuja Declaration, African Union (AU) member states committed to end the continent's health financing crisis by pledging to allocate 15% of their annual national budgets to healthcare. But over two decades later, only three countries, Rwanda, Botswana, and Cape Verde, have consistently met or exceeded the target. The World Health Organization (WHO) reports that over 30 AU member states allocate less than 10% of their budget to health, with some allocating as little as 5-7%. "Nigeria has been fluctuating between 4-6% of the annual budget," said Atiku, adding that politicians are only concerned about other infrastructure development projects like roads. "Doctors and health care professionals are always going on strike because they are underpaid," she said. Inadequate public financing of health has resulted in poorly run, underperforming health systems across many African countries. "Over reliance on external funding is highly unsustainable and inconsistent with achieving Universal Health Coverage," said Itai Rusike, of the Zimbabwe-based Community Working Group on Health. "The Abuja target of 15% allocation to health has remained an elusive target. It is now outdated given the population increase, huge disease burden and the levels of neglect of infrastructure and health worker retention," Rusike added. A chronic lack of specialized treatment and facilities is driving many African patients to seek medical treatment abroad. The sectors affected include oncology, cardiology, neurology, orthopedics, organ transplants, fertility, and pediatrics for the management of rare genetic disorders. Over 300,000 Africans travel to India annually for medical services, spending more than $2 billion each year. India is said to be generating more than $6 billion each year from medical tourism. Projections show the Asian country could get $13 billion in medical tourism by 2026 under the "Heal in India" initiative. According to the African Journal of Hospitality, Tourism and Leisure, Nigerians are estimated to spend $1 billion annually on medical tourism. 60% of that amount is spent on oncology, orthopedics, nephrology, and cardiology. Additionally, the figure represents almost 20% of the annual public health expenditure that covers the salaries of health workers. An estimated 5,000 Nigerians fly out of the country monthly for medical treatment, with large numbers traveling to India. Some African health authorities argue they are doing their best to improve healthcare for their countries. "There is room for improvement to fund the health sector. We are targeting to ensure by 2027 at least 17,000 primary health care facilities are functional in Nigeria," Nigeria's Minister of State for Health and Social Welfare, Iziaq Adekunle Salako, told DW. "There is not a health system in the world that is 100%. We believe we are headed in the right direction in implementing solutions." Health experts say African governments need to build modern health facilities to offer services currently being outsourced abroad. "Looking up to politicians will not work. Communities need to come together and pull resources to create health care systems that work for them," health rights advocate Chamunorwa Mashoko told DW. In 2016, the continental lender Afreximbank launched a support facility to build specialized health facilities across Africa to reduce outbound medical tourism. The initial target would focus on the establishment of a center of excellence for cancer patients. Tanzania, Nigeria, Kenya and Ghana were identified as suitable to host the facilities. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video :
DW
6 days ago
- DW
Fake medication is a problem across the world – DW – 07/31/2025
Demand for drugs, including weight-loss injections, is sending people to dangerous places to get their medicine. But spotting dodgy marketplaces is not easy. Amid rising demand for popular medications, experts and industry groups are concerned that regulators may not be able to keep pace with the speed of counterfeiters. "A doctor simply writes down the prescription. They don't care where the patient buys the drug," said Saifuddin Ahmed, a public health practitioner and epidemiologist at Johns Hopkins University in the US. "It is critically important that a healthcare provider should be engaged. The [regulators are] not enough," Ahmed told DW. Nowhere else is the challenge more obvious than with the huge demand for products like Wegovy and Zepbound. They contain active compounds called semaglutide or tirzepatide, which were originally designed to treat type 2 diabetes. But these drugs were found to have a side effect that triggered substantial, sustained weight loss. Demand rose from people wanting to lose weight, and that caused a shortage. Fakes have filled the gap. Drug counterfeiting is a major global problem. The World Health Organization (WHO) estimates that 1 in 10 pharmaceuticals are fakes that carry no guarantee of any health benefits. While this is mainly in low-and-middle income countries, especially parts of Africa and Asia, around 1% of people in high-income nations also obtain medication from unregulated sources. In some cases, these drugs may have no effect. In other cases, however, ingredients in the fake may lead to adverse reactions or create new health problems. "Purchasing medicine online from unregulated, unlicensed sources can expose patients to potentially unsafe products that have not undergone appropriate evaluation or approval, or do not meet quality standards," said the US regulator, the Food and Drug Administration (FDA) in 2023, when it issued its first warnings about the problem. In 2024, the WHO issued a global warning that batches of fake Ozempic were flooding the black market. More recently, in July 2025, data from the UK National Pharmacy Association found 1 in 5 Britons had attempted to obtain weight loss treatments in the previous year. It warned that the high demand for these medicines carried the risk that people would "resort to unregulated online suppliers instead of regulated pharmacies." Unregulated pharmaceuticals are being sold via online-only pharmacies, international drug shopping and organized criminal distributors. These digital marketplaces are not online stores for established pharmacies, but sites that seemingly offer medicine at a fraction of the usual cost. The drugs may look identical to genuine medicines online, but when delivered often have spelling errors on the packet or incorrect ingredient listings. But it's not only fake drugs or placebos. Regulators have raised concern about compounding, where medicines that have been approved individually can be formulated to produce non-regulated "compounds" for individual patients. In some regions of the world, including the US, trained pharmacists are allowed to compound medicines, but even then, the practice is less regulated than the stringent approvals that drug manufacturers must meet to bring their products to market. For example, when the FDA temporarily allowed the compounding of weight loss drugs to address a product shortage, some pharmacists used semaglutide salts — which are not approved by regulators — instead of semaglutide itself. This led to reports of side effects. And it was not just trained compounding pharmacies that were formulating these products in the US. Ahmed said, "this is done in [places] like gymnasiums and spas." The FDA has now stopped allowing compounded versions of these weight loss drugs, but it is concerned that unregulated online pharmacies are still making substandard products available. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video To address concerns that consumers may seek unsafe products from unregulated sources, the FDA operates a campaign called BeSafeRx that provides guidance for consumers to identify genuine pharmaceuticals. In the European Union, safety features on medicines are mandated, and include standardized labelling practices. In a statement provided to DW, the European Medicines Agency said "patients should only use online retailers registered with the national competent authorities in the EU Member States, to reduce the risk of buying substandard or falsified medicines." Europol, which is responsible for law enforcement for pharmaceutical crime across member states, has coordinated regular actions across the bloc in collaboration with US and Colombian partners. In a 2023 operation, more than 1,284 people were charged for offenses related to the trafficking of counterfeit and misused medicines and doping substances. As well as local awareness campaigns and enforcement initiatives, the key measure, Ahmed said, was to help improve awareness between patients and their health practitioners. Ahmed heads the Johns Hopkins University's BESAFE initiative, which investigates risks and interventions to prevent the uptake of substandard and counterfeit medication. Surveys undertaken by BESAFE have found that within the US and South Africa, awareness of where to safely buy prescriptions and report fakes or adverse events is low. He said building trust between consumers, medical practitioners and regulators may help avoid the risks of counterfeit and unregulated drug purchases.
DW
30-07-2025
- DW
The Good Virus – DW – 07/30/2025
Is there an effective alternative to antibiotics? Researchers around the world are focusing on bacteriophages. These "good" viruses infect specific bacteria and destroy them. Do they offer a way out of the antibiotics crisis? Every year, around 1.3 million people die because of antibiotic resistance. According to the World Health Organization (WHO), this is one of the biggest threats to global health. There are various reasons for the growing number of antibiotic resistances: Unspecific or incorrect use of antibiotics causes bacteria to mutate into multi-resistant germs. In addition, the excessive use of antibiotics in animal husbandry has alarming consequences for humans: Antibiotics, which were considered one of medicine's greatest achievements against infections, are increasingly losing their effectiveness. Increasingly, science is relying on the potential of bacteria-eating viruses, or bacteriophages, to combat bacteria. Researchers from the US, Georgia, Kenya and Uganda are developing suitable phage therapies and establishing international collaborations. And they're finding what they're looking for in bacteria-contaminated wastewater. Phage samples from the US and African countries will help to build up a biobank and produce specific phage cocktails. Phage therapy has not yet been approved in Germany due to a lack of clinical studies. However, in some countries, such as Georgia and Slovakia, bacteriophages are being used successfully to treat patients with antibiotic resistances. DW English FRI 15.08.2025 – 01:15 UTC FRI 15.08.2025 – 04:15 UTC SAT 16.08.2025 – 13:15 UTC SUN 17.08.2025 – 19:15 UTC MON 18.08.2025 – 09:15 UTC MON 18.08.2025 – 16:15 UTC MON 18.08.2025 – 21:15 UTC WED 20.08.2025 – 12:15 UTC Lagos UTC +1 | Cape Town UTC +2 | Nairobi UTC +3 Delhi UTC +5,5 | Bangkok UTC +7 | Hong Kong UTC +8 London UTC +1 | Berlin UTC +2 | Moscow UTC +3 San Francisco UTC -7 | Edmonton UTC -6 | New York UTC -4
